title: Prognostic scoring systems in MDS.
abstract: Prognostic scoring systems in myelodysplastic syndromes are useful tools in order to get in idea on the expected course of the disease and offer patients a risk adapted treatment. Several good scores have been developed, the international prognostic scoring system (IPSS) being the gold standard for 15 years, now validated and refined. As more and more patients receive therapy and drugs are approved, the major goal for future projects must be the identification of predictive parameters and scoring systems in order to predict the response and outcome after specific treatments.
authors.affiliation: Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University of Duesseldorf, Duesseldorf, Germany. Germing@med.uni-duesseldorf.de
authors.forename: Ulrich
authors.initials: U
authors.lastname: Germing
authors.forename: Andrea
authors.initials: A
authors.lastname: Kündgen
mesh_terms: D015415:Biomarkers / Q000032:analysis; D001773:Blood Cells / Q000473:pathology*; D001853:Bone Marrow / Q000473:pathology*; D006801:Humans; D007621:Karyotyping; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology*; D011237:Predictive Value of Tests; D011379:Prognosis; D012107:Research Design; D012306:Risk; D016019:Survival Analysis
chemical_list: D015415:Biomarkers